This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Headquartered in Woonsocket, RI, CVS Health Corporation (formerly known as CVS Caremark Corporation) is a pharmacy innovation company with integrated offerings across the entire spectrum of pharmacy care. On Sep 3, 2014, CVS Caremark Corporation announced a change of its corporate name to CVS Health to reflect its broader health care commitment. In Nov 2018, CVS Health completed the $70-billion consolidation of insurance-giant Aetna. With the acquisition, the segments of CVS Health have been realigned.
Top Research Reports for Alphabet, Eli Lilly & CVS Health
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Alphabet (GOOGL), Eli Lilly (LLY) and CVS Health (CVS).
Zacks Value Trader Highlights: Amazon, Citigroup, CVS and Lincoln National
by Zacks Equity Research
Zacks Value Trader Highlights: Amazon, Citigroup, CVS and Lincoln National
What is a Value Stock?
by Tracey Ryniec
With Berkshire Hathaway buying shares of Amazon, it's time for a refresher on what makes a stock a value.
Bull of the Day: Tabula Rasa HealthCare (TRHC)
by Kevin Cook
Exploding medical data is being harnessed by this $1.2 billion IT integrator and patient safety innovator
Company News For May 2, 2019
by Zacks Equity Research
Companies in the news are: AAPL, CVS, TAP and RCL
CVS Health (CVS) Surpasses Q1 Earnings and Revenue Estimates
by Zacks Equity Research
CVS Health (CVS) delivered earnings and revenue surprises of 8.00% and 1.94%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?
CVS Health's (CVS) Q1 Earnings Top Estimates, EPS View Up
by Zacks Equity Research
Year-over-year growth in CVS Health's (CVS) top line is aided by a strong Pharmacy Services segment, benefiting from the upside in specialty services.
This Week's Must-See Earnings Charts
by Tracey Ryniec
Which stocks will traders be watching this busy earnings week? These are some of those at the top of the list.
Will Pharmacy Services Drive CVS Health's (CVS) Q1 Earnings?
by Zacks Equity Research
Within Pharmacy Services, despite a fierce pricing competition, CVS Health (CVS) is currently riding on high level of service and execution, competitive pricing and a unique integrated model.
CVS Health (CVS) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
CVS Health (CVS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
CVS Health (CVS) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
CVS Health (CVS) closed at $52.96 in the latest trading session, marking a +1.01% move from the prior day.
CVS Health (CVS) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, CVS Health (CVS) closed at $53.90, marking a -0.59% move from the previous day.
CVS Health (CVS) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, CVS Health (CVS) closed at $54.18, marking a +0.22% move from the previous day.
Amazon (AMZN) Stock Looks Like a Buy Heading into Q1 2019 Earnings
by Benjamin Rains
Shares of Amazon (AMZN) have outpaced the market in 2019, up 21% against the S&P's 15% jump. Despite the strong start, Amazon stock rests over 11% below its 52-week high. So, let's take a look at why Amazon appears to be a buy right now heading into its Q1 2019 earnings release .
The Zacks Analyst Blog Highlights: Walgreens, Amazon and CVS
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Walgreens, Amazon and CVS
Aging Demography, Consolidation Brighten HMO Industry Outlook
by Sapna Bagaria
Increasing retirement population, industry consolidation, growth of ancillary business and easing of regulatory changes promise solid growth for the HMO industry.
What to Expect from CVS' Q1 Earnings After Walgreens Stock Tanks
by Benjamin Rains
CVS Health (CVS) stock has been down in the dumps for years and shares have already fallen 20% in 2019 even as the broader market booms. Now, after Walgreens Boots Alliance's (WBA) massive one-day, post-earnings selloff Tuesday, it's time to see what investors should expect from CVS.
Walgreens Has Biggest One-Day Loss in 5 year: What Does This Mean For Pharmacies?
by Daniel Laboe
Walgreens Boots Alliance (WBA) dropped over 12% today taking the price down to a low of $55, the lowest the stock has traded at since 2014. WBA???s tumble was initiated by worse than expected earnings, and a full year EPS guidance adjustment which would make them flat for 2019.
CVS Health (CVS) Gains But Lags Market: What You Should Know
by Zacks Equity Research
In the latest trading session, CVS Health (CVS) closed at $54.19, marking a +0.48% move from the previous day.
Buy Walgreens (WBA) Stock Ahead of Q2 Earnings, Before CBD Push?
by Benjamin Rains
Shares of Walgreens Boots Alliance, Inc. (WBA) have fallen roughly 9% this year, which stands in contrast to the market's nearly 13% climb and its industry's 4.5% average gains. But is it time to buy WBA stock ahead of earnings?
CVS Health (CVS) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, CVS Health (CVS) closed at $55.50, marking a +1% move from the previous day.
Better Buy Amid Tech Diversification: Apple (AAPL) vs. Amazon (AMZN) Stock
by Benjamin Rains
Apple (AAPL) and Amazon (AMZN) are two of the largest companies on the planet. The tech powers have reshaped industries and changed the way millions of people function on a daily basis. But today, Apple and Amazon face possible transition periods as they try to expand their offerings to drive growth. So which stock, AAPL or AMZN, is a better buy?
Why Is CVS Health (CVS) Down 7.9% Since Last Earnings Report?
by Zacks Equity Research
CVS Health (CVS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
CVS Health (CVS) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
CVS Health (CVS) closed the most recent trading day at $56.16, moving -1.63% from the previous trading session.
Amazon's HSA & FSA Payment Option to Boost Pharma Initiatives
by Zacks Equity Research
Amazon (AMZN) rolls out payment options via HSA and FSA for medical purchases made on its online platform which is likely to strengthen its healthcare market presence.